28.4
Acute Kidney Injury IV: Diagnostic Studies and Prevention
View the full transcript and gain access to JoVE Core videos
Q1: What are the three main categories of causes in acute kidney injury diagnosis?
AKI diagnosis identifies three cause categories: prerenal (dehydration, hypotension, blood loss), intrarenal (nephrotoxic drugs, contrast media), and postrenal (urinary obstructions like kidney stones or tumors). Understanding these categories guides diagnostic workup and treatment decisions. Medical history helps determine which category applies to each patient.
Q2: Why is oliguria considered an early sign of kidney dysfunction compared to serum creatinine?
Reduced urine output (oliguria) appears early in kidney dysfunction, while serum creatinine increases only after more than 50% of kidney function is lost. This delay makes oliguria a more sensitive early indicator. Monitoring urine output allows clinicians to detect kidney injury before creatinine levels rise significantly.
Q3: How does urinalysis help differentiate between prerenal and intrarenal causes of AKI?
Prerenal AKI shows normal urine sediment, while intrarenal AKI reveals abnormalities including hematuria, pyuria, casts, or crystals indicating tubular damage or infection. These findings help distinguish the injury location and guide targeted treatment. Urinalysis is essential for narrowing the diagnostic differential.
Q4: What imaging approach is recommended to detect obstructions while minimizing contrast exposure?
Renal ultrasound is the first-line imaging tool to assess kidneys without contrast agent exposure, detecting anatomical abnormalities and urinary obstructions. CT scans reveal masses, lesions, or vascular abnormalities in complex cases. This approach protects high-risk patients from contrast-induced nephropathy while providing diagnostic information.
Q5: How does IV saline hydration prevent contrast-induced kidney injury?
Hydration with intravenous normal saline before and after procedures involving contrast agents is the most effective prevention strategy for contrast-induced nephropathy. Adequate fluid volume maintains kidney perfusion and dilutes nephrotoxic contrast media. This intervention is essential for at-risk patients undergoing coronary angiography or similar procedures.
Q6: Which medications increase AKI risk and require careful monitoring or dose adjustment?
Nephrotoxic drugs including NSAIDs and aminoglycosides significantly increase AKI risk, particularly in patients with chronic kidney disease, diabetes, or heart failure. NSAIDs pose elevated risk in heart failure or cirrhosis patients. Monitoring kidney function and adjusting dosages in high-risk populations reduces injury likelihood.
Q7: What preventive measures address infection-related kidney damage in AKI management?
Prompt infection treatment prevents sepsis and accelerates kidney damage prevention. Removing urinary catheters as soon as possible prevents catheter-related infections. Regular monitoring of urine output, serum electrolytes, and fluid balance enables early detection and management of acute kidney injury complications.